Biovara closes a £ 1 million equity capital raise at an £ 8m pre-money valuation.

4 November, 2026|

Biovara closes a £ 1 million equity capital raise at an £ 8m pre-money valuation.

Related news

Professor Jaclyn Smith – regarded as world leading expert on chronic cough, including Lung Cancer Cough, endorses Biovara’s clinical approach

Biovara approves share capital split prior to fund raising

ACF Research publication of independent thematic research note on Lung Cancer Cough market